Philip L. McCarthy MD

Philip McCarthy

Philip L. McCarthy
MD

Contact Information
Roswell Park Cancer Institute
Carlton & Elm Streets
Buffalo, New York 14263
Phone: (716) 845-3360
plm1@buffalo.edu



Employment:

  • Professor, Medicine, Roswell Park Comprehensive Cancer Center Jacobs School of Medicine & Biomedical Sciences (2014-present)


Journal Articles:

See all (21 more)

Abstracts:

  • Hahn T, Benekli M, Wong C, Moysich K, Hyland A, Michalek AM, Alam A, Baer MR, Bernstein ZP, Bambach BJ, Chanan-Khan AA, Czuczman MS, Wetzler M, McCarthy PL. (2003) A Prognostic Model for Prolonged Event-Free Survival After Autologous or Allogenic Blood or Marrow Transplantation for Relapsed and Refractory Hodgkin‘s Disease. (Nov) 485b-485b
  • McCarthy PL, Hahn T, Cooper M, Brady A, Miller A, Baer MR, Bambach BJ, Bernstein S, Bernstein Z, Czuczman MS, Slack JL, Wetzler M, Herzig G, Stewart C. (2000) Analysis of OKT3 for Acute Graft-versus-Host Disease (GVHD) Prophylaxis in Allogeneic Bone Marrow Transplant (BMT) Patients. (Nov) 11-11
  • Hepgur M, Saito NG, Hahn T, Starostik P, Wallace P, Bambach BJ, Higman MA, Dubel K, McCarthy PL, Khan A, Battiwalla M. (2010) Atypical Presentation of Vaginal GvHD with Multiple Abdominal Pain Crisis. (Feb) S315-S315
  • Jupudy V, Shaukat A, Hahn T, Rondeau C, Miller A, Alam A, Baer MR, Bambach BJ, Bernstein S, Bernstein Z, Chanan-Khan AA, Czuczman MS, Slack JL, Wetzler M, Mookerjee BK, Proulx G, McCarthy PL. (2001) Comparison of High Intensity versus Low Intensity Conditioning Regimens on Renal Toxicity in Allogenic Blood or Marrow Transplant (Allo BMT) Patients. (Nov)
  • Hepgur M, Saito NG, Hahn T, Starostik P, Wallace P, Bambach BJ, Higman MA, Dubel K, McCarthy PL, Battiwalla M. (2010) Early Complete Donor Lymphoid Chimerism with Fludarabine, Melphalan and Low Dose (400CGY) Total Body Irradiation Reduced Intensity Conditioning. (Feb) S291-S291
  • Wojtaszczyk JA, Hahn T, Battiwalla M, Baer MR, Wang ES, Barcos MP, Bambach BJ, Padmanabhan S, Wetzler M, McCarthy PL. (2006) Effect of Bone Marrow Hypoplasia Secondary to Reinduction Therapy for Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) on Outcomes after Blood and Marrow Transplantation (BMT). (Nov) 3033-3033
  • Liu H, Hahn T, Wilding G, Groman A, Bambach BJ, Higman MA, Ross M, Chen GL, McCarthy PL. (2011) Fludarabine, Melphalan and Low Dose Total Body Irradiation for Reduced Intensity Conditioning (RIC) Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT). (Nov) 4570-4570
  • Alam A, Ahuja N, Hahn T, Baer MR, Bambach BJ, Bernstein S, Bernstein Z, Chanan-Khan AA, Czuczman MS, Slack JL, Wetzler M, McCarthy PL. (2001) Fludarabine/Melphalan (Flu/Mel) Conditioning Regimen for Allogenic Blood or Marrow Transplantation (Allo BMT) in Patients Undergoing Second Transplantation. (Nov)
  • Benekli M, Hahn T, Hernandez L, Miller A, Alam A, Baer MR, Bambach BJ, Bernstein S, Bernstein ZP, Chanan-Khan AA, Czuczman MS, Slack JL, Wetzler M, Becker JL, Stewart C, McCarthy PL. (2001) Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Mobilized Donor Bone Marrow Stem Cells Along with GM-CSF Administration Post Allogenic Bone Marrow Transplantation to Reduce the Incidence of Graft-versus-Host Disease (GVHD): Phase II Pilot Study. (Nov)
  • Alam A, Varma H, Hahn T, Segal BH, Paplham P, Becker JL, Baer MR, Bambach BJ, Silva J, Slack JL, Wetzler M, McCarthy PL. (2002) Infectious Complications in Long-Term Survivors of Cord Blood Stem Cell Transplantation (CBSCT): Experience at Roswell Park Cancer Institute. (Nov)
  • Hahn T, Roy HN, Cooper M, Paplham P, Alam A, Baer MR, Bambach BJ, Chanan-Khan AA, Czuczman MS, Wetzler M, Segal BH, McCarthy PL. (2003) Oral Beclomethasone Dipropionate for Treatment of Steroid-Refractory Acute or Chronic Gastrointestinal Graft-versus-Host Disease After Blood or Marrow Transplantation (BMT). (Nov) 446b-446b
  • Simon M, Hahn T, Ford LA, Anderson B, Swinnich D, Baer MR, Bambach BJ, Bernstein S, Bernstein Z, Czuczman MS, Slack JL, Wetzler M, Herzig G, Schriber J, McCarthy PL. (2000) Possible Benefit of Low Molecular Weight Heparin (LMWH) for Hepatic VOD Prophylaxis After BMT. (Nov)
  • Hahn T, Nagubandi M, Ford L, Milk B, Baer MR, Bambach BJ, Bernstein S, Bernstein Z, Czuczman MS, Slack JL, Wetzler M, Lipman B, McCarthy PL. (1998) Seasonal Variation in Adenovirus Infections in Blood and Marrow Transplant (BMT) Patients. (Nov)
  • Alam A, Lawrence D, Hahn T, Ford L, Dascomb S, Bambach BJ, Baer MR, Bernstein S, Bernstein ZP, Czuczman MS, Chanan-Khan AA, Slack JL, Wetzler M, Proulx G, McCarthy PL. (2001) Thrombotic Thrombocytopenic Purpura (TTP) in Allogenic Bone Marrow Transplant (Allo BMT) Risk Factors and Effect on Outcome: An Update on the Experience at RPCI. (Nov)
  • Alan A, Ford L, Nagubandi M, Baer MR, Bambach BJ, Bernstein S, Bernstein Z, Czuczman MS, Huang W, Slack JL, Wetzler M, Milk B, McCarthy PL. (1998) Treatment of Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome (TTP/HUS) Associated with Allogenic BMT: Lack of Impact on Final Outcome. (Nov)
  • Wetzler M, Baer MR, Slack JL, Ford L, McCarthy PL, Bambach BJ. (2000) Umbilical Cord Blood Transplantation (UCBT) for Adult Chronic Myeloid Leukemia (CML) Patients - A Single Institution Experience. (Nov)
  • Hahn T, Alam A, Miller A, Meteer J, Dascomb S, Baer MR, Bambach BJ, Bernstein S, Bernstein Z, Chanan-Khan AA, Czuczman MS, Slack JL, Wetzler M, Becker JL, Stewart C, McCarthy PL. (2001) Use of Donor Lymphocyte Infusions (DLI) for Treatment of Relapse After Allogenic Bone Marrow Transplantation (AMBT): Effective GVT in Chronic Myeloid Leukemia (CML) with No Clinical GVHD. (Nov)
See all (7 more)


School News:

In the Media:


Clinical Specialties:

Clinical Offices:

Insurance Accepted:



Contact Information

Roswell Park Cancer Institute
Carlton & Elm Streets
Buffalo, New York 14263
Phone: (716) 845-3360
plm1@buffalo.edu